Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers-Reference-Cited by-同舟云学术

Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers

Published:2017-05 Issue: Volume:85 Page:293-304
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Zuo Shuguang,Wen Yuqing,Panha Hean,Dai Gongpeng,Wang Liping,Ren Xuequn,Fu Kanda

Funder

National Natural Science Foundation of China

Outstanding Youth Science Foundation of Henan university

Natural Science Foundation of Henan Province

Science and Technology Development Program of Henan Province

Key Project of Scientific and Technological Research of Henan Educational Committee

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference49 articles.

1. Treatment of advanced leukemia in mice with mRNA engineered T cells;Barrett;Hum. Gene Ther.,2011

2. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains;Carpenito;Proc. Natl. Acad. Sci. U. S. A.,2009

3. Chimeric antigen receptor-engineered T cells for immunotherapy of cancer;Cartellieri;J. Biomed. Biotechnol.,2010

4. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha;Ebel;Cancer Immun.,2007

5. Bispecific antibodies for targeted cellular cytotoxicity;Fanger;Trends Biotechnol.,1991

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

2. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

3. Navigating immunotherapy for ovarian cancer: current landscape and future perspectives;Journal of Cancer Metastasis and Treatment;2024-06-26

4. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

5. FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective;Molecular Biotechnology;2024-03-08